Apollo Hospitals Enterprise Limited vs Cohance Lifesciences Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Cohance Lifesciences Limited (COHANCE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs COHANCE on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
98.58
13.46
P/B ratio
4.36
0.22%
Dividend yield
1.35%
₹135.04
EPS
₹4.69

Profitability

APOLLOHOSP takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
4.58%
17.31%
Return on capital
5.67%
14.94%
EBITDA margin
18.82%
7.94%
Net margin
6.62%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
19.17%
33.35%
Profit CAGR (3Y)
-28.53%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹17,751 Cr
₹25,229 Cr
Revenue
₹2,269 Cr
₹2,003 Cr
Net profit
₹150 Cr
0.90
Debt / equity
0.10
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.1% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.98 times its book value"]
Cohance Lifesciences Limited
  • + ["Company has delivered good sales growth of 17.6% CAGR over last 5 years"]
  • − ["The company has delivered a poor profit growth of -16.2% over past five years.", "Though the company is reporting repeated profits, it is not paying out dividend"]
Apollo Hospitals Enterprise Limited full analysis Cohance Lifesciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.